[(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate

C19H23ClFN3O5 — CID 22086275

IUPAC[(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate
SMILESCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](C)O[C@H]1n1c(NC(C)C)nc2cc(Cl)c(F)cc21
InChIInChI=1S/C19H23ClFN3O5/c1-8(2)22-19-23-14-6-12(20)13(21)7-15(14)24(19)18-17(29-11(5)26)16(9(3)27-18)28-10(4)25/h6-9,16-18H,1-5H3,(H,22,23)/t9-,16-,17-,18-/m1/s1
InChIKeyDZTDDVMUXVSWQH-BKPUXCOXSA-N
MW427.86 g/mol
LogP3.43
Rot. Bonds5

About [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate

[(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate (PubChem CID 22086275) has the molecular formula C19H23ClFN3O5 and a molecular weight of 427.86 g/mol. Its IUPAC name is [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate.

Molecular Properties

Compound Name[(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate
PubChem CID22086275
Molecular FormulaC19H23ClFN3O5
Molecular Weight427.86 g/mol
Exact Mass427.13
IUPAC Name[(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate
SMILESCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](C)O[C@H]1n1c(NC(C)C)nc2cc(Cl)c(F)cc21
InChIInChI=1S/C19H23ClFN3O5/c1-8(2)22-19-23-14-6-12(20)13(21)7-15(14)24(19)18-17(29-11(5)26)16(9(3)27-18)28-10(4)25/h6-9,16-18H,1-5H3,(H,22,23)/t9-,16-,17-,18-/m1/s1
InChIKeyDZTDDVMUXVSWQH-BKPUXCOXSA-N
XLogP3.43
TPSA91.68 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500427.86
LogP ≤ 53.43
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate?
The IUPAC name of [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate (CID 22086275) is [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate.
What is the SMILES notation for [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate?
The canonical SMILES for [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate is CC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](C)O[C@H]1n1c(NC(C)C)nc2cc(Cl)c(F)cc21.
What is the InChIKey of [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate?
The InChIKey is DZTDDVMUXVSWQH-BKPUXCOXSA-N. The full InChI is InChI=1S/C19H23ClFN3O5/c1-8(2)22-19-23-14-6-12(20)13(21)7-15(14)24(19)18-17(29-11(5)26)16(9(3)27-18)28-10(4)25/h6-9,16-18H,1-5H3,(H,22,23)/t9-,16-,17-,18-/m1/s1.
What are the key properties of [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate?
[(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate has a molecular weight of 427.86 g/mol, XLogP of 3.43, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5R)-4-acetyloxy-5-[5-chloro-6-fluoro-2-(propan-2-ylamino)benzimidazol-1-yl]-2-methyloxolan-3-yl] acetate is sourced from PubChem (CID 22086275), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).